SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Art Pappas will be a panelist at the Small and Emerging Private Equity Manager Conference, organized by Credit Suisse's Customized Fund Investment Group, in Houston.
News | 04. 19. 2007
